MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

Similar documents
Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Cryptogenic Strokes: Evaluation and Management

PFO Management update

Cryptogenic Stroke: A logical approach to a common clinical problem

Management and Investigation of Ischemic Stroke By Etiology

What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

Alex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and

Practical Considerations in the Early Treatment of Acute Stroke

Significant Relationships

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

Stroke/TIA. Tom Bedwell

Acute Stroke Treatment: Current Trends 2010

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Endovascular Neurointervention in Cerebral Ischemia

ENDOVASCULAR THERAPIES FOR ACUTE STROKE


ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

Carotid Artery Stenting

2/7/

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012

Acute stroke update 2016 innovations in managing ischemic and hemorrhagic disease

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Carotid Artery Stenting

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

TIA: Updates and Management 2008

True cryptogenic stroke

ACUTE CENTRAL PERIFERALEMBOLISM

ACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare

Karl Meisel, MD MA Director of Stroke Clinic University of California San Francisco

Alan Barber. Professor of Clinical Neurology University of Auckland

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Mechanical Thrombectomy of Large Vessel Occlusions Using Stent Retriever Devices

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Watchman and Structural update..the next frontier. Ari Chanda, MD Cardiology Associates of Fredericksburg

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

Review of clinical carotid stent procedural & long-term outcomes in. symptomatic asymptomatic. patients

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

CEREBRO VASCULAR ACCIDENTS

Peter A. Soukas, M.D., FACC, FSVM, FSCAI, RPVI

Endovascular Treatment for Acute Ischemic Stroke: Curtis A. Given II, MD Co-Director, Neurointerventional Services Baptist Physician Lexington

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough

2018 Update in Diagnosis and Management of Stroke

I, (Issam Moussa) DO NOT have a financial interest/arrangement t/ t or affiliation with one or more organizations that could be perceived as a real

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC

Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center

2015 Update in Diagnosis and Management of Stroke

Permanent foramen ovale: when to close?

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Ischemic stroke: management, prevention and follow up. Amit Kansara MD Providence Stroke Center Providence Brain and Spine Institute

Nicolas Bianchi M.D. May 15th, 2012

Session Antiplatelet Therapy: How, Why and When? In patients with ischemic stroke/tia

Case 1 5/26/2017 ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE

Stroke School for Internists Part 1

How Can We Properly Manage Patients With Stroke of Undetermined Origin?

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital

Symptoms of small vessel strokes. Small Vessel stroke. What is this? Treatment. Large Vessel stroke 6/1/2018

Endovascular Treatment of Ischemic Stroke

CVA. Alison Atwater PA-C

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

Speakers. 2015, American Heart Association 1

APPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL

From interventional cardiology to cardio-neurology. A new subspeciality

Alan Barber. Professor of Clinical Neurology University of Auckland

How to Evaluate Patients with Cryptogenic Stroke

Michael Horowitz, MD Pittsburgh, PA

PATENT FORAMEN OVALE: UPDATE IN MANAGEMENT OF RECURRENT STROKE KATRINE ZHIROFF, MD, FACC, FSCAI LOS ANGELES CARDIOLOGY ASSOCIATES

CVA Updates Karen Greenberg, DO, FACOEP. Director Neurologic Emergency Department Crozer Chester Medical Center

Sixth Annual Intensive Update in Neurology 9/15-16/2016. W Tom Kushner DO Swedish Stroke Clinic Neurohospitalist

Advances in Neuro-Endovascular Care for Acute Stroke

Asif Serajian DO FACC FSCAI

Primary Care Atrial Fibrillation Update: Anticoagulation and Left Atrial Appendage Occlusion. Greg Francisco, MD, FACC

Cryptogenic Stroke/PFO with Thrombophilia and VTE: Do We Know What To Do?

Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology

About 700,000 Americans each year suffer a new or recurrent stroke. On average, a stroke occurs every 45 seconds

2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17

Cerebrovascular Disease

Oltre la terapia medica nelle dissezioni carotidee

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one:

Stroke Case Studies. Dr Stuti Joshi Neurology Advanced Trainee Telestroke fellow

Why Should We Treat PFO?

Interventional Neuroradiology. & Stroke INR PROCEDURES INR PROCEDURES. Dr Steve Chryssidis. 25-Sep-17. Interventional Neuroradiology

Management of cervicocephalic arterial dissection. Ciro G. Randazzo, MD, MPH Thomas Jefferson University Hospital, Department of Neurosurgery

Secondary Stroke Prevention: A Precautionary Tale

Antithrombotic Summit Basel 2012 Basel, 26. April Peter T. Buser Klinik Kardiologie Unviersitätsspital Basel

Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Alex Abou-Chebl, MD Medical Director, Stroke Baptist Health, Louisvile. Alex Abou-Chebl, MD

Is Stroke Frequency Declining?

Mark J. Alberts, MD, FAHA, FANA Vice-Chair, Dept of Neurology Professor of Neurology UT Southwestern Medical Center Dallas, TX

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

Carotid Artery Stenting

Interventional Revolution in Treatment of Stroke

Transcription:

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist neurointerventionist Steve Ramee, MD Ochsner Medical Center New Orleans

DISCLOSURE Nothing Nothing to disclose.

Percentage Breakdown of Deaths from Cardiovascular Diseases United States: 2001 Source: CDC/NCHS. p5

Age-Adjusted Death Rates for Coronary Heart Disease, Stroke, and Lung and Breast Cancer for White and Black Females United States: 2001 Source: CDC/NCHS. p7

Don t hurt my brain, its my second favorite organ. Woody Allen

Birth of a Neurointervention Program: 1994 Carotid bifurcation is causative in less than 1/3 of all TIA s and strokes! Other lesion locations do not have established surgical therapy: Aorto-ostial ostial stenosis Subclavian stenosis Vertebrobasilar disease Intracranial stenosis PFOPFO Atrial Atrial fibrillation These patients need treatment, too!

Each specialty has deficiencies Cardiologists lack a fund of knowledge. Neuroradiologists lack clinical skills. Neurologists lack angiographic skills. Neuroradiology FUND OF KNOWLEDGE Neurology or Neurosurgery ANGIO SKILLS CLINICAL SKILLS CARDIOLOGY

Ochsner Multidisciplinary Neurovascular Team Components Emergency Medicine Stroke Stroke Neurology Radiology Interventional Neuroradiology Non-invasive Cardiology Interventional Cardiology Internal Internal Medicine Vascular Vascular Surgery Physical Physical Medicine

What they do with Stroke and TIA patients ER Physicians Dx/triage TIA & stroke Stroke neurology Clinical evaluation/tcd Initiate stroke therapy Referral for intervention Radiology CFD/CT/MRI Neuroradiology Angiography Intracranial intervention Vascular Surgery Elective CEA Non-invasive cardiology Echocardiogram/TEE Critical care service Interventional cardiology Intracranial intervention Stroke intervention Carotid/veertebral stents PFO/ASD/LAA closure Internal Medicine Inpatient service Physical Medicine Rehabilitation

Major Types of Stroke Ischemic = 83% Hemorrhagic = 17%

What causes ischemic stroke? Different than MI. The intracranial vessels are usually normal. Embolic occlusion rather than intracranial plaque rupture Extracranial sources in 85%: Carotid plaque Cardioembolic Atrial appendage LV thrombus PFO Carotid dissection

Normal cerebral anatomy ACA: Lower extremity MCA: Upper extremity, speech Lenticulo-striate arteries ACA M1 M2 ICA Anterior Lateral

Normal Vertebral Artery Symptoms Dizziness Gait disturbances Blurred or double vision Syncope All brainstem functions Thalamoperforator a.

ANATOMY

Localization Simplified Cerbral cortex Nearly always Embolic Aphasia Neglect Visual Field Loss Hemiplegia Sensory Loss

Localization Simplified Lacunar cerebral Nearly always Thrombotic Pure Motor Hemiplegia Pure Sensory Mixed Motor Sensory Ataxic Hemiparesis No cortical signs

Localization Simplified Brainstem Embolic or Thrombotic Diplopia Nausea/Vomiting Crossed Findings Vertigo

We Aren t Doing Very Well: Managing Acute Stroke Patients 97% 97% of all stroke patients get NO therapy at all! 97% 97% of all stroke lawsuits are for non- treatment, NOT bad outcomes! 63% of stroke patients arrive at hospital > 24 hours after symptom onset! From Alberta, MJ et al. Stroke 1992;23:352-356 356

In Our ER s: IV Lytics are ONLY effective if given within 3 hrs of symptom onset! Up to 90 min 2.8x better outcomes than placebo 90min - 3 hrs 1.5x better than placebo Over Over 3 hrs M 1 occlusion Multiple failed trials Poor outcome w/ i.v. lysis Marler et al. Neurology. 2000;55:1649-1655.

Or in Our Neuro-Intervention Suites: Intra-arterial Thrombolysis Prolyse in Acute Cerebral Thromboembolism (PROACT) II 180 patients with occlusion of middle cerebral artery within 6 hours of onset Recanalization Intraarterial Prourokinase (9mg) vs placebo Follow-up 3 months Pro-urokinase Placebo 66% 18% Hemorrhagic transformation 10% 2% Favorable outcome 40% 25%

Health Economics Hospital charges for Stroke Patients Stroke patients who receive a thrombolytic agent have significantly higher in-hospital charges but are currently small in number Of all discharges in DRGs 14 & 15 N (% of Total) LOS Mean Std. Charges Mean Patients receiving a thrombolytic identified by code 99.10 2,452 (0.76%) 7.1 $31,765 99% get NO Rx! Patients not receiving a thrombolytic 321,757 (99.24%) 5.6 $16,400 Source: 2003 Medicare MedPAR data. Thrombolytic patients coded with ICD-9 code 99.10.

Technique of Stroke Intervention

Catheter-based approach Time Time is brain Target Target vessel angiography first Other vessels only if dx is in question Cross Cross lesion with hydrophilic wire If soft thrombus: Lysis, balloon, stent If hard thrombus: Merci, balloon, stent Remember: Primum non-nocere nocere!

Acute Stroke Intervention 39 year old woman Mother of 4 yo boy Sudden collapse in shower at 5AM Dense R hemiplegia, aphasia CT showed MCA sign What would YOU do?

Four days later...

Concentric Retrieval System

12 RESULTS: NIH Stroke Scale 25 Patients with Acute Hemiplegic Stroke Ramee et al, Stroke, May 2004 Presentation versus 30 day outcome 13.3 P = 0.0001 8 4 3.6 0 Baseline 30 days

RESULTS: Modified Rankin Score 25 Patients with Acute Hemiplegic Stroke Ramee et al, Stroke, May 2004 Baseline versus 30 day outcome 4 3 2 3.6 P = 0.0001 1.6 1 0 Baseline 30 days

What about Stroke Prevention?

What About Stroke Prevention? It s much easier than treatment! TIA is an ominous warning sign. Many patients have no warning TIA. Must treat underlying conditions that predispose to stroke.

The Heart and Aortic Arch as a Source of Preventable Ischemic Stroke Aortic arch and vertebral ostial stenosis ~25% ~15% Thrombotic IC cerebral and vertebral stenosis Cardioembolic Atrial fibrillation Akinetic segment Mitral stenosis Prosthetic valve Myxoma Cardiomyopathy ~25% ~30% Cryptogenic > 50-70% with PFO and ASD

IBNA\Folders\A\ATRITECH\BOLT\PPS\ 0210_0392_IBNA\main\ 0210_0392_IBNA_SCAtrial fibrillation source of stroke is a MAJOR Up to 25% of all ischemic strokes occur in patients with AF Percent of total strokes attributable to atrial fibrillation 35% 30% 25% 20% 15% 10% 5% 0% Source: Stroke, 1991, 22(8): 938 8 50 59 60 69 70 79 80 89 Age group (years) Patients with AF have, on average, 5 to 6 times greater probability of having a stroke and 18 times greater probability of an embolic event 35% of patients with AF who are not treated with anticoagulants will have a stroke in their lifetime An estimated 55% of AF patients require anticoagulation therapy due to risk of stroke

Atrial Fibrillation and Stroke WATCHMAN Device by Atritech RCT 300 PTS 2:1 Randomization Atritech vs.. Warfarin

Frustration: Cryptogenic Stroke Antiquated historical term Pts with no carotid disease or afib 50-70% RA have a PFO! LA RA PRA Confirmed by TCD, TEE with bubble study LA PLA On Valsalva, PRA > PLA

Recurrence Rates on Medical Therapy in Cryptogenic Stroke 17% Stroke or death @ 2 yr!! WARSS study NIH funded RCT 2606 patients randomized to ASA or Warfarin Excluded other sources of stroke (Afib, carotid dz.) Recurrent event = stroke or death at 2 years. Warfarin group 17.8% Aspirin group 16.0% Mohr et al, NEJM 2001, vol 345, 1444.

Remember our young mother with MCA occlusion?

Four days later... One month later, PFO closure

What about symptomatic intracranial stenosis?

How effective is medical Rx? WASID Trial NEJM 2005;352,1305-16 16

WASID Trial Double blind, Multicenter RCT 569 patients with TIA or Stroke 50-99% stenosis by angiography Warfarin (INR 2-3) 2 vs.. ASA 1300mg Primary Endpoint @ 2years: Ischemic Stroke Brain Hemorrhage Death (non-neurologic, neurologic, vascular) NEJM 2005;352,1305-16

Two Year Stoke and Death 22% NEJM 2005;352,1305-16

PTA result

Elective Intracranial Intervention Freedom from events at one year 100% 80% 60% 40% 20% N = 26 patients 100% Neurologic evaluation 100% 93% 0% TIA Stroke Ramee et al, CCI 52:457-467, 467, 2001

Who can prevent it? Neurologists Neuro-radiologists Neurosurgeons Cardiologists Radiologists Vascular Surgeons Internists TIA and Stroke It s up to All Of US at this meeting and our colleagues to prevent strokes They aren t referred to a neurologist until AFTER they have had one!

SUMMARY Stroke is a medical emergency. High morbidity, mortality, and cost Second only to CAD 85% of all strokes are embolic. 25% Atrial fibrillation 30% Cryptogenic 30% Atheroembolic Stroke patients are best managed by a multidisciplinary team. Interventional cardiologists are well suited to participate and provide stroke intervention. Stroke prevention much easier than stroke treatment and is our responsibility!

STROKE